Financial statements A-Vita Pharm
Balance sheet of A-Vita Pharm
Company age:
Age:
22 y. 4 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of A-VITA PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 177 384,94 | 776 949,58 | 815 444,41 | 848 147,49 | 1 123 239,16 | 1 120 493,47 |
| A. Fixed assets | 0,00 | 29 503,82 | 43 250,45 | 80 940,32 | 101 663,98 | 124 299,90 |
| B. Current assets | 177 384,94 | 747 445,76 | 772 193,96 | 767 207,17 | 1 021 575,18 | 996 193,57 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 177 384,94 | 776 949,58 | 815 444,41 | 848 147,49 | 1 123 239,16 | 1 120 493,47 |
| A. Equity | -227 528,11 | -331 017,97 | -371 423,37 | -377 360,61 | -259 383,15 | -408 733,39 |
| B. Liabilities and provisions for liabilities | 404 913,05 | 1 107 967,55 | 1 186 867,78 | 1 225 508,10 | 1 382 622,31 | 1 529 226,86 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | 376 822,05 | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.